A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity

NCT00983645 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Insufficient funding

Conditions

Renal Transplant Rejection

Interventions

DRUG: Prograf
DRUG: Neoral

Sponsor

Loma Linda University